about
Breast cancer 1, early onsetNerve growth factorUbiquitin protein ligase E3ASMAD family member 7Mitogen-activated protein kinase 9Angiopoietin 1Sphingosine kinase 1Adrenergic receptor, beta 2Leucine-rich repeat kinase 2BRCA1 DNA repair associatedCheckpoint with forkhead and ring finger domainsPTTG1 interacting proteinFA complementation group ITBC1 domain family member 7Innate immunity activatorProteasome 26S subunit, non-ATPase 10Arrestin beta 2Arrestin beta 1Axin 1NSE3 homolog, SMC5-SMC6 complex componentFKBP prolyl isomerase 1ACDK5 regulatory subunit associated protein 3NHL repeat containing E3 ubiquitin protein ligase 1Cullin 3DnaJ heat shock protein family (Hsp40) member A3Receptor interacting serine/threonine kinase 2Baculoviral IAP repeat containing 2Baculoviral IAP repeat containing 8Ras association domain family member 1PTEN induced kinase 1Ras association domain family member 5Ubiquitin BCopper metabolism domain containing 1MALT1 paracaspaseF-box and WD repeat domain containing 7Centromere protein XFamily with sequence similarity 107 member AUbiquilin 1Caveolin 1Ring finger protein 111
P682
LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteinsToward a confocal subcellular atlas of the human proteomeBRCA1 participates in DNA decatenationE6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core proteinNedd4 family interacting protein 1 (Ndfip1) is required for ubiquitination and nuclear trafficking of BRCA1-associated ATM activator 1 (BRAT1) during the DNA damage responseTSPYL5 suppresses p53 levels and function by physical interaction with USP7
P921
Q14862232-001768A5-C3D4-4AA0-B068-E429B363BC07Q14873936-53262885-6A47-420E-A381-B07691864676Q14878332-79571925-3183-404A-A7EE-F27AE7CDB294Q14904377-C9B8B191-8AC5-4D1A-9899-D9B8046B9971Q14906673-2EB053AB-93AF-49A7-A700-F0B642BC34AEQ14912180-0BABD622-04B6-4D53-B963-C47E98309F9FQ14913839-59DF21CD-05CB-4D67-B22B-0BE9B569BA5FQ14916386-22D53AFD-677D-4C29-8E03-158FCCEE728CQ15331171-C6BD5A8E-B21C-4261-B109-7A9341B146BDQ17487737-8B93AE17-EA57-44B2-AA16-0780F148E509Q21100748-2FEA94F1-C6CF-4110-A1DC-E3DE877A6B5AQ21100813-5267A9F5-CAED-4BD4-BD36-B57EF25672A8Q21101224-288355E5-90A5-4062-A90E-6ADECBF3F77BQ21103269-209B9E42-0E9E-4189-8F89-94E5BEAE2BDDQ21105503-67C92D17-2DB0-4DDF-BE9A-B5343FD4992CQ21105503-ABBD7C2F-0C8D-4279-9AE8-596D321E8AF1Q21107941-BAD3F42C-85C6-4058-9C94-9B8FC490D4BAQ21109248-CEBADFEC-CB1E-44DD-9729-246750E34AD3Q21109259-203A5819-916A-43D8-8A08-47DC2E921FF8Q21109410-2B2707CA-8E16-45BB-8C85-8021B5B63A3CQ21110077-0C04B4F9-A5CD-4100-A43E-E36A7BC44786Q21110396-184DE0E7-83B9-4E09-B009-5A74AC91B1D5Q21110691-E5375739-6286-4D7C-A732-42C70EA61964Q21110884-283B9326-04D3-4BA9-8F09-641B74B659F9Q21111152-038440BB-BBEA-45A3-83DF-FCB21FB84B3BQ21111409-05283986-3C7F-498E-83EE-47E37B4C781FQ21111679-A024860B-E034-4CB4-BF35-807F32810C2DQ21111704-005F2924-910B-4C47-80D5-76F1CDA13FECQ21111726-6F396481-08D8-42EC-821D-A627B7D62A1CQ21112140-957C7F84-6B88-4CE3-ACF5-FFF670F48920Q21112306-01766DB5-C68C-4A93-ADD6-B89497523DC3Q21112644-FD6CB82A-A18F-407C-ABCB-CC734F5F3631Q21112968-FC34730F-8AB9-4C78-AEB1-BF30F51AD95BQ21113001-2D31C40A-42DA-49D1-8145-DA0DDD8A6912Q21113001-53C5CE04-81D8-4C77-B723-A2568682FB7BQ21113910-B9D5B73A-5AE2-4818-96EA-17AAFF9DD757Q21113973-D8EB8443-5C26-46B6-A0FA-749605E3A46DQ21114075-0D2E6574-6E25-490B-A6B6-25168D04E9EFQ21114419-2AA0990E-B8AA-495B-A397-412ECA347FDEQ21115143-64525BC9-04D0-4CEE-806E-F14DE733588D
P682
description
Any process that activates or ...... ubiquitin groups to a protein.
@en
biologisch proces
@nl
name
positive regulation of protein ubiquitination
@en
type
label
positive regulation of protein ubiquitination
@en
altLabel
GO:0031398
@en
up regulation of protein ubiquitination
@en
up-regulation of protein ubiquitination
@en
upregulation of protein ubiquitination
@en
prefLabel
positive regulation of protein ubiquitination
@en
P279
P2888
P686
GO:0031398